Prevention of Heart Failure With SGLT-2 Inhibition:Insights From CVD-REAL
Farkouh ME, Verma S
Journal of the American College of Cardiology. 2018;71(22):2507-10
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
SGLT-2 Inhibitors and Cardiovascular Risk:An Analysis of CVD-REAL
Cavender MA, Norhammar A, Birkeland KI, et al.
Journal of the American College of Cardiology. 2018;71(22):2497-506
Leggi
Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial
Dobson R, Whittaker R, Jiang Y, et al.
BMJ 2018;361:k1959
Leggi
Associations of health literacy with diabetic foot outcomes: a systematic review and meta-analysis
Chen PY, Elmer S, Callisaya M, et al.
Diabet Med. Pub. online 26 May 2018
Leggi
Relation of Subclinical Hypothyroidism is Associated with Cardiovascular Events and All-Cause Mortality in Adults With High Cardiovascular Risk
Moon S, Kong SH, Choi HS, et al.
Am J Cardiol. Pub. Online 17 May 2018
Leggi
Comparison of Long-Term Survival Benefits with Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Versus Without Diabetes Mellitus (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT])
Kutyifa V, Naqvi SY, Brown M, et al.
Am J Cardiol. 2018;121(12):1567-74
Leggi
Use of GLP-1 RAs in Cardiovascular Disease Prevention: A Practical Guide
Lingvay I, Leiter LA
Circulation 2018;137:2200-2
Leggi
Hyperkalaemia in people with diabetes: occurrence, risk factors and outcomes in a Danish population-based cohort study
Thomsen RW, Nicolaisen SK, Adelborg K, et al.
Diab Med Pub. online 23 May 2018
Leggi
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
David E Kandzari, Michael Böhm, Felix Mahfoud et al.
The Lancet. Pub. online 23 May 2018
Leggi
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
Azizi M, Schmieder RE, Mahfoud F, et al.
Lancet. Pub. online 23 May 2018.
Leggi